Oceania Cruises Successfully Installs Starlink Internet on Entire Fleet

Oceania Cruises Rolls Out High-Speed Satellite WiFi on All Ships MIAMI, Dec. 4, 2024 /PRNewswire/ — Oceania Cruises, the world’s leading culinary- and destination-focused cruise line, has announced that the installation of the world’s first and largest satellite constellation, Starlink, has been completed on all ships, providing all guests with high-speed, unlimited WiFi included as…

Read More

Introducing Craig Schneider: Oppenheimer’s New Regional Director of Michigan

Charmingly Eccentric Wealth Management Veteran Appointed as Regional Director for Oppenheimer & Co. Inc. Introduction Oppenheimer & Co. Inc. (Oppenheimer), a leading investment bank and wealth manager, has recently appointed Craig Schneider as the Regional Director of its Michigan Region. Schneider brings over 25 years of industry experience to this role, further solidifying Oppenheimer’s presence…

Read More

Empowering Communities: Centene Foundation Joins Forces with National Association of Community Health Centers to Enhance Healthcare Delivery

Three-Year Partnership to Improve Maternal and Child Health Outcomes ST. LOUIS, Dec. 4, 2024 /PRNewswire/ The Centene Foundation’s Commitment The Centene Foundation (“The Foundation”), the philanthropic arm of Centene Corporation (“Centene”) [NYSE: CNC], has recently announced a new three-year partnership with the National Association of Community Health Centers (“NACHC”). This partnership aims to increase the…

Read More

Bispecific Antibody APVO442: A Precision Treatment for Prostate Cancer with Reduced Side Effects

Aptevo Therapeutics Announces Breakthrough in Cancer Treatment Revolutionizing Cancer Therapy with ADAPTIR-FLEX® Platform Seattle, WA – Aptevo Therapeutics Inc. (NASDAQ:APVO) continues to make waves in the biotechnology industry with its latest announcement regarding the development of APVO442, a preclinical bispecific antibody targeting difficult-to-treat prostate cancer. This groundbreaking molecule is the first of its kind to…

Read More

Clever and Unconventional Advertising: Clear Channel Outdoor Takes Over 100 Private Terminals

Clever, personable, and wonderfully unconventional – Early Arrival Multi-Year Deal Lands as Air Travel Soars Clear Channel Outdoor’s Airports Division Continues to Innovate Advertising Programs NEW YORK, Dec. 4, 2024 /PRNewswire/ — Clear Channel Outdoor’s Airports Division, the Americas-based airports business of Clear Channel Outdoor Holdings, Inc. (NYSE: CCO), today announced that through a five-year…

Read More

Revolutionizing Wet AMD Treatment: Outlook Therapeutics Receives NICE Recommendation for LYTENAVA (bevacizumab-gamma)

Exciting News for Wet AMD Patients: LYTENAVA™ Receives Positive Reimbursement Decision First Positive Reimbursement Decision Worldwide for LYTENAVA™ LYTENAVA™ has made history as the first and only approved ophthalmic formulation of bevacizumab for the treatment of wet AMD in the European Union (EU) and United Kingdom (UK). This groundbreaking approval opens up new possibilities for…

Read More